Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (29648)	12/15/1999 9:45:00 AM
From: WTDEC	Read Replies (1) \| Respond to of 32384

Henry, I have rarely seen a WS firm offer a correction on something like this. They do reissue reports sometimes with the corrections made, but they don't tell you what changed. So, unless you read it with the old one alongside or just remember what was wrong, you don't know why it was reissued. BTW, I heard from a second WS source (Molowa at BearS put this in his report yesterday) who didn't see the BearS report that they feel there is a small but real possibility that the FDA will give the OK for early stage CTCL. Do you have any view on such an outcome? Best regards, Walter